NAYA Biosciences (NASDAQ:NAYA – Get Free Report) was upgraded by equities research analysts at Maxim Group from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a $2.00 target price on the stock. Maxim Group’s price objective would suggest a potential upside of 316.58% from the stock’s previous close.
NAYA Biosciences Price Performance
NAYA opened at $0.48 on Thursday. The firm’s fifty day simple moving average is $0.76. NAYA Biosciences has a 52-week low of $0.41 and a 52-week high of $3.50.
About NAYA Biosciences
Featured Articles
- Five stocks we like better than NAYA Biosciences
- 3 REITs to Buy and Hold for the Long Term
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Do ETFs Pay Dividends? What You Need to Know
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Earnings Per Share Calculator: How to Calculate EPS
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for NAYA Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NAYA Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
